Regulation of proteases by protein inhibitors of the serpin superfamily

Progress in Molecular Biology and Translational Science

Volumn 99, Issue C, 2011, Pages 185-240

  Olson, Steven T ^a   Gettins, Peter G W ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Allostery; Exosites; Heparin; Protease; Protease inhibitor; Protein engineering; Serpin

Indexed keywords

EID: 78751614085     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385504-6.00005-1     Document Type: Chapter

References (167)

1. P. Gettins Serpin structure, mechanism, and function Chem Rev 102 2002 4751 4803
2. G.A. Silverman, J.C. Whisstock, S.P. Bottomley, J.A. Huntington, D. Kaiserman, and C.J. Luke Serpins flex their muscle: putting the clamps on proteolysis in diverse biological systems J Biol Chem 285 2010 24299 24305
3. P.G.W. Gettins, and S.T. Olson Exosite determinants of serpin specificity J Biol Chem 284 2009 20441 20445
4. W. Bode, and R. Huber Natural protein proteinase inhibitors and their interaction with proteinases Eur J Biochem 204 1992 433 451
5. 1 -proteinase inhibitor Biochem Biophys Res Commun 95 1980 864 871
6. R.W. Carrell, and J. Travis α1-Antitrypsin and the serpins: variation and countervariation Trends Biochem Sci 10 1985 20 24
7. C.A. Ray, R.A. Black, S.R. Kronheim, T.A. Greenstreet, P.R. Sleath, and G.S. Salvesen Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1beta converting enzyme Cell 69 1992 597 604
8. G.A. Silverman, P.I. Bird, R.W. Carrell, F.C. Church, P.B. Coughlin, and P.G.W. Gettins The serpins are an expanding superfamily of structurally similar but functionally diverse proteins J Biol Chem 276 2001 33293 33296
9. J.A. Irving, R.N. Pike, A.M. Lesk, and J.C. Whisstock Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function Genome Res 10 2000 1845 1864
10. C. Benarafa, and E. Remold-O'Donnell The ovalbumin serpins revisited: perspective from the chicken genome of clade B serpin evolution in vertebrates Proc Natl Acad Sci USA 102 2005 11367 11372
11. H. Ragg, T. Lokot, P.-B. Kamp, W.R. Atchley, and A. Dress Vertebrate serpins: construction of a conflict-free phylogeny by combining exon-intron and diagnostic site analyses Mol Biol Evol 18 2001 577 584
12. H.H. Van Boven, and D.A. Lane Antithrombin and its inherited deficiency states Semin Hematol 34 1997 188 204
13. W.P. Fay, A.D. Shapiro, J.L. Shih, R.R. Schleef, and D. Ginsburg Complete deficiency of plasminogen-activator inhibitor type 1 due to a frameshift mutation N Engl J Med 327 1992 1729 1733
14. 1 -antitrypsin Nature 298 1982 329 334
15. A.E. Davis III, P. Mejia, and F. Lu Biological activities of C1 inhibitor Mol Immunol 45 2008 4057 4063
16. G.A. Silverman, J.C. Whisstock, D.J. Askew, S.C. Pak, C.J. Luke, and S. Cataltepe Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis Cell Mol Life Sci 61 2004 301 325
17. J. Cooley, T.K. Takayama, S.D. Shapiro, N.M. Schechter, and E. Remold-O'Donnell The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites Biochemistry 40 2001 15762 15770
18. F.L. Scott, C.E. Hirst, J. Sun, C.H. Bird, S.P. Bottomley, and P.I. Bird The intracellular serpin proteinase inhibitor 6 is expressed in monocytes and granulocytes and is a potent inhibitor of the azurophilic granulae protease, cathepsin G Blood 93 1999 2089 2097
19. C.H. Bird, V.R. Sutton, J. Sun, C.E. Hirst, A. Novak, and S. Kumar Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway Mol Cell Biol 18 1998 6387 6398
20. F. Gao, H.Y. Shi, C. Daughty, N. Cella, and M. Zhang Maspin plays an essential role in early embryonic development Development 131 2004 1479 1489
21. K. Ishiguro, T. Kojima, K. Kadomatsu, Y. Nakayama, A. Takagi, and M. Suzuki Complete antithrombin deficiency in mice results in embryonic lethality J Clin Invest 106 2000 873 878
22. N. Nagai, M. Hosokawa, S. Itohara, E. Adachi, T. Matsushita, and N. Hosokawa Embryonic lethality of molecular chaperone Hsp47 knockout mice is associated with defects in collagen biosynthesis J Cell Biol 150 2000 1499 1505
23. M. Simonovic, P.G.W. Gettins, and K. Volz Crystal structure of viral serpin crmA provides insights into its mechanism of cysteine proteinase inhibition Protein Sci 9 2000 1423 1427
24. M. Renatus, Q. Zhou, H.R. Stennicke, S.J. Snipas, D. Turk, and L.A. Bankston Crystal structure of the apoptotic suppressor CrmA in its cleaved form Structure 8 2000 789 797
25. J.A. Irving, L.D. Cabrita, J. Rossjohn, R.N. Pike, S.P. Bottomley, and J.C. Whisstock The 1.5 A crystal structure of a prokaryote serpin: controlling conformational change in a heated environment Structure 11 2003 387 397
26. C.M. Hekman, and D.J. Loskutoff Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants J Biol Chem 260 1985 11581 11587
27. J. Mottonen, A. Strand, J. Symersky, R.M. Sweet, D.E. Danley, and K.F. Geoghegan Structural basis of latency in plasminogen activator inhibitor-1 Nature 355 1992 270 273
28. D.A. Lawrence, S.T. Olson, S. Palaniappan, and D. Ginsburg Engineering plasminogen activator inhibitor 1 mutants with increased functional stability Biochemistry 33 1994 3643 3648
29. 1 -Proteinase inhibitor crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function J Mol Biol 177 1984 531 556
30. G. Kaslik, J. Kardos, L. Szabo, P. Zavodszky, W.M. Westler, and J.L. Markely Effects of serpin binding on the target proteinase: global stabilization, localized increased structural flexibility, and conserved hydrogen bonding at the active site Biochemistry 36 1997 5455 5474
31. C. Boudier, and J.G. Bieth The reaction of serpins with proteinases involves important enthalpy changes Biochemistry 40 2001 9962 9967
32. M.B. Berkenpas, D.A. Lawrence, and D. Ginsberg Molecular evolution of plasminogen activator inhibitor-1 functional stability EMBO J 14 1995 2969 2977
33. A. Zhou, J.A. Huntington, and R.W. Carrell Formation of the antithrombin heterodimer in vivo and the onset of thrombosis Blood 94 1999 3388 3396
34. P.J. Declerck, M. De Mol, M.C. Alessi, S. Baudner, E.P. Paques, and K.T. Preissner Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma identification as a multimeric form of S protein (vitronectin) J Biol Chem 263 1988 15454 15461
35. J.C. Whisstock, G.A. Silverman, P.I. Bird, S.P. Bottomley, D. Kaiserman, and C.J. Luke Serpins flex their muscle: structural insights into target peptidase recognition, polymerization and transport functions J Biol Chem 285 2010 24307 24312
36. B. Gooptu, and D.A. Lomas Conformational pathology of the serpins: themes, variations, and therapeutic strategies Annu Rev Biochem 78 2009 147 176
37. A. Zhou, P. Stein, J. Huntington, and R. Carrell Serpin polymerization is prevented by a hydrogen bond network that is centered on His-334 and stabilized by glycerol J Biol Chem 278 2003 15116 15122
38. B. Gooptu, B. Hazes, W.W. Chang, T.R. Dafforn, R.W. Carrell, and R.J. Read Inactive conformation of the serpin alpha1-antchymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease Proc Natl Acad Sci USA 97 2000 67 72
39. T.R. Dafforn, R. Mahadeva, P.R. Elliott, P. Sivasothy, and D.A. Lomas A kinetic mechanism for the polymerization of alpha1-antitrypsin J Biol Chem 274 1999 9548 9555
40. P. Elliott, D. Lomas, R. Carrell, and J. Abrahams Inhibitory conformation of the reactive loop of antitrypsin Nat Struct Biol 3 1996 676 681
41. M. Yamasaki, W. Li, D.J.D. Johnson, and J.A. Huntington Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization Nature 455 2008 1255 1258
42. M.H. Yu, K.N. Lee, and J. Kim The Z type variation of human alpha 1-antitrypsin causes a protein folding defect Nat Struct Biol 2 1995 363 367
43. 1 -antitrypsin accumulation in the liver Nature 357 1992 605 607
44. J.R. Dahlen, F. Jean, G. Thomas, D.C. Foster, and W. Kisiel Inhibition of soluble recombinant furin by human proteinase inhibitor 8 J Biol Chem 273 1998 1851 1854
45. C. Schick, P.A. Pemberton, G.P. Shi, Y. Kamachi, S. Cataltepe, and A.J. Bartuski Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis Biochemistry 37 1998 5258 5266
46. Q. Zhou, S. Snipas, K. Orth, M. Muzio, V.M. Dixit, and G.S. Salvesen Target protease specificity of the viral serpin CrmA. Analysis of five caspases J Biol Chem 272 1997 7797 7800
47. L.T. Quan, A. Caputo, R.C. Bleackley, D.J. Pickup, and G.S. Salvesen Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A J Biol Chem 270 1995 10377 10379
48. J. Dobo, and P.G.W. Gettins α1-Proteinase inhibitor forms initial non-covalent and final covalent complexws with elastase analogously to other serpin-proteinase pairs, suggesting a common mechanism of inhibition J Biol Chem 279 2004 9264 9269
49. L. Hedstrom Serine protease mechanism and specificity Chem Rev 102 2002 4501 4523
50. E. Stratikos, and P.G.W. Gettins Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into β-sheet A Proc Natl Acad Sci USA 96 1999 4808 4813
51. D.A. Lawrence, D. Ginsburg, D.E. Day, M.B. Berkenpas, I.M. Verhamme, and J. Kvassman Serpin-protease complexes are trapped as stable acyl-enzyme intermediates J Biol Chem 270 1995 25309 25312
52. S.V. Calugaru, R. Swanson, and S.T. Olson The pH dependence of serpin-proteinase complex dissociation reveals a mechanism of complex stabilization involving inactive and active conformational states of the proteinase which are perturbable by calcium J Biol Chem 276 2001 32446 32455
53. P.A. Patston, P. Gettins, J. Beechem, and M. Schapira Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate Biochemistry 30 1991 8876 8882
54. 1 -proteinase inhibitor Pittsburgh and antithrombin with proteinases J Biol Chem 278 2003 37881 37887
55. A. Dementiev, M. Petitou, J.-M. Herbert, and P.G.W. Gettins The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity Nat Struct Mol Biol 11 2004 863 867
56. A. Dementiev, J. Dobo, and P.G.W. Gettins Active-site distortion is sufficient for proteinase inhibition by serpins J Biol Chem 281 2006 3452 3457
57. J.A. Huntington, R.J. Read, and R.W. Carrell Structure of a serpin-protease complex shows inhibition by deformation Nature 407 2000 923 926
58. S. Ye, A.L. Cech, R. Belmares, R.C. Bergstrom, Y. Tong, and D.R. Corey The structure of a Michaelis serpin-protease complex Nat Struct Biol 8 2001 979 983
59. T. Baglin, R. Carrell, F. Church, C. Esmon, and J. Huntington Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism Proc Natl Acad Sci USA 99 2002 11079 11084
60. W. Li, D.J. Johnson, C.T. Esmon, and J.A. Huntington Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin Nat Struct Mol Biol 11 2004 857 862
61. D.J. Johnson, W. Li, T.E. Adams, and J.A. Huntington Antithrombin-S195A factor Xa-heparin structure reveals the mechanism of antithrombin activation EMBO J 25 2006 2029 2037
62. D.J.D. Johnson, J. Langdown, and J.A. Huntington Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7 A structure of the ternary complex Proc Natl Acad Sci USA 107 2010 645 650
63. W. Li, T.E. Adams, J. Nangalia, C.T. Esmon, and J.A. Huntington Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex Proc Natl Acad Sci USA 105 2008 4661 4666
64. I. Schechter, and A. Berger On the size of the active site in proteases. I. Papain Biochem Biophys Res Commun 27 1967 157 162
65. 15 N HSQC NMR as a sensitive nonperturbing monitor of conformation Biochemistry 39 2000 11884 11892
66. 1 -proteinase inhibitor pittsburgh-trypsin covalent complex Biochemistry 40 2001 6284 6892
67. P.G.W. Gettins, M. Backovic, and F.C. Peterson Use of NMR to study serpin function Methods 32 2004 120 129
68. A. Futamura, E. Stratikos, S.T. Olson, and P.G.W. Gettins Change in environment of the P1 side chain upon progression from the Michaelis complex to the covalent serpin-proteinase complex Biochemistry 37 1998 13110 13119
69. E. Stratikos, and P. Gettins Major proteinase movement upon stable serpin-proteinase complex formation Proc Natl Acad Sci USA 94 1997 453 458
70. M. Backovic, E. Stratikos, D.A. Lawrence, and P.G.W. Gettins Structural similarity of the covalent complexes formed between the serpin plasminogen activator inhibitor-1 and the arginine-specific proteinases trypsin, LMW urokinase, HMW urokinase and tPA: use of site-specific fluorescent probes of local environment Protein Sci 11 2002 1182 1191
71. 1 -antichymotrypsin as seen by enhanced sensitivity to proteolysis Biochemistry 35 1996 10608 10615
72. P.E. Bock, S.T. Olson, and I. Bjrk Inactivation of thrombin by antithrombin is accompanied by inactivation of regulatory exosite 1 J Biol Chem 272 1997 19837 19845
73. R. Swanson, M.P. Raghavendra, W. Zhang, C. Froelich, P.G.W. Gettins, and S.T. Olson Serine and cysteine proteases are translocated to similar extents upon formation of covalent complexes with serpins. Fluorescence perturbation and fluorescence resonance energy transfer mapping of the protease binding site in CrmA complexes with granzyme B and caspase-1 J Biol Chem 282 2007 2305 2313
74. J. Dobo, R. Swanson, G.S. Salvesen, S.T. Olson, and P.G.W. Gettins Cytokine response modifier a inhibition of initiator caspases results in covalent complex formation and dissociation of the caspase tetramer J Biol Chem 281 2006 38781 38790
75. P. Gettins, and B. Harten Properties of thrombin- and elastase-modified human antithrombin III Biochemistry 27 1988 3634 3639
76. M. Bruch, V. Weiss, and J. Engel Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites J Biol Chem 263 1988 16626 16630
77. 1 -antitrypsin and its association with protease inhibitor function J Biol Chem 275 2000 16904 16909
78. A. Zhou, R.W. Carrell, and J.A. Huntington The serpin inhibitory mechanism is critically dependent on the length of the reactive center loop J Biol Chem 276 2001 27541 27547
79. L.D. Tesch, M.P. Raghavendra, T. Bedsted-Faarvang, P.G.W. Gettins, and S.T. Olson Specificity and reactive loop length requirements for CrmA inhibition of serine proteases Protein Sci 14 2005 533 542
80. K. Barker-Carlson, D. Lawrence, and B. Schwartz Acyl-enzyme complexes between tissue-type plasminogen activator and neuroserpin are short-lived in vitro J Biol Chem 277 2002 26852 32768
81. X. Huang, R. Swanson, G.J. Broze Jr., and S.T. Olson Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa J Biol Chem 283 2008 29770 29783
82. P.G.W. Gettins The F-helix of serpins plays an essential, active role in the proteinase inhibition mechanism FEBS Lett 523 2002 2 6
83. N. Vleugels, A. Gils, A.-P. Bijnens, I. Knockaert, and P. Declerck The importance of helix F in plasminogen activator inhibitor-1 Biochim Biophys Acta 1476 2000 20 26
84. 2 -antiplasmin, angiotensinogen, and ovalbumin Biochemistry 30 1991 1723 1730
85. G. Joslin, R.J. Fallon, J. Bullock, S.P. Adams, and D.H. Perlmutter The SEC receptor recognizes a pentapeptide neodomain of alpha 1-antitrypsin-protease complexes J Biol Chem 266 1991 11282 11288
86. S. Stefansson, S. Muhammad, X.-F. Cheng, F.D. Battey, D.K. Strickland, and D.A. Lawrence Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein J Biol Chem 273 1998 6358 6366
87. I.R. Horn, B.M.M. Van den Berg, S.K. Moestrup, H. Pannekoek, and A.J. van Zonneveld Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator Thromb Haemost 80 1998 822 828
88. J.K. Jensen, K. Dolmer, and P.G.W. Gettins Specificity of binding of the low density lipoprotein receptor-related protein (LRP) to different conformational states of the clade E serpins PAI-1 and PN-1 J Biol Chem 284 2009 17989 17997
89. A. Kasza, H.H. Petersen, C.W. Heegaard, K. Oka, A. Christensen, and A. Dubin Specificity of serine proteinase-serpin complex binding to very-low-density lipoprotein receptor and α2-macroglobulin receptor low-density-lipoprotein-receptor-related protein Eur J Biochem 248 1997 270 281
90. 2 -antiplasmin-protease complexes in mice Thromb Hemost 48 1982 208 210
91. 1 -antitrypsin-trypsin complexes is mediated by the low density lipoprotein receptor-related protein J Biol Chem 271 1996 6523 6529
92. A.P. Lillis, I. Mikhailenko, and D.K. Strickland Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability J Thromb Haemost 3 2005 1884 1893
93. A.P. Lillis, L.B. van Duyn, J.E. Murphy-Ullrich, and D.K. Strickland LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies Phys Rev 88 2008 887 918
94. K. Beatty, J. Bieth, and J. Travis Kinetics of association of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotrypsin J Biol Chem 255 1980 3931 3934
95. 1 -proteinase inhibitor (Pittsburgh) with trypsin-like serine proteinases Biol Chem Hoppe Seyler 367 1986 853 859
96. E.P. Bianchini, V.B. Louvain, P.-E. Marque, M.A. Juliano, L. Juliano, and B.F. Le Bonniec Mapping of the catalytic groove preferences of factor Xa reveals an inadequate selectivity for its macromolecule substrates J Biol Chem 277 2002 20527 20534
97. 1 -antitrypsin) Biochemistry 19 1980 3973 3978
98. M.I. Plotnick, N.M. Schechter, Z.M. Wang, X. Liu, and H. Rubin Role of the P6-P3′ region of the serpin reactive loop in the formation and breakdown of the inhibitory complex Biochemistry 36 1997 14601 14608
99. C.A. Ibarra, G.E. Blose, T.D. Christian, and J.D. Shore The contribution of the exosite residues of plasminogen activator inhibitor-1 to proteinase inhibition J Biol Chem 279 2004 3643 3650
100. S. Braud, B.F. Le Bonniec, C. Bon, and A. Wisner The stratagem utilized by the plasminogen activator from the snake Trimeresurus stejnegeri to escape serpins Biochemistry 41 2002 8478 8484
101. V.C. Chen, L. Chao, and J. Chao A postively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibitor by acting as a secondary binding site for kallikrein J Biol Chem 275 2000 40371 40377
102. A.R. Rezaie, J.-S. Bae, C. Manithody, S.H. Qureshi, and L. Yang Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z J Biol Chem 283 2008 19922 19926
103. A.R. Rezaie, C. Manithody, and L. Yang Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor J Biol Chem 280 2005 32722 32728
104. X. Huang, A. Dementiev, S.T. Olson, and P.G.W. Gettins Basis for the specificity and activation of the serpin protein Z-dependent proteinases inhibitor as an inhibitor of membrane-associated factor Xa J Biol Chem 285 2010 20399 20409
105. A.R. Rezaie, M.-F. Sun, and D. Gailani Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity Biochemistry 45 2006 9427 9433
106. 444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition J Biol Chem 265 1990 5623 5628
107. J.P. Sheehan, D.M. Tollefsen, and J.E. Sadler Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans J Biol Chem 269 1994 32747 32751
108. V.M. Van Deerlin, and D.M. Tollefsen The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans J Biol Chem 266 1991 20223 20231
109. I. Verhamme, P.E. Bock, and C.M. Jackson The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II J Biol Chem 279 2004 9785 9795
110. S.T. Olson, R. Swanson, E. Raub-Segall, T. Bedsted, M. Sadri, and M. Petitou Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin Thromb Haemost 92 2004 929 939
111. J.M. Hermans, and S.R. Stone Interaction of activated protein C with serpins Biochem J 295 1993 239 245
112. M. Djie, S. Stone, and B. Le Bonniec Intrinsic specificity of the reactive site loop of antitrypsin, antichymotrypsin, antithrombin III, and protease nexin I J Biol Chem 272 1997 16268 16273
113. P.C.R. Hopkins, R.N. Pike, and S.R. Stone Evolution of serpin specificity: cooperative interactions in the reactive-site loop sequence of antithrombin specifically restrict the inhibition of activated protein C J Mol Evol 51 2000 507 515
114. T. Mather, V. Oganessyan, P. Hof, R. Huber, S. Foundling, and C.T. Esmon The 2.8 crystal structure of Gla-domainless activated protein C EMBO J 15 1996 6822 6831
115. J.A. Huntington, S.T. Olson, B. Fan, and P.G.W. Gettins Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding Biochemistry 35 1996 8495 8503
116. L. Jin, J.P. Abrahams, R. Skinner, M. Petitou, R.N. Pike, and R.W. Carrell The anticoagulant activation of antithrombin by heparin Proc Natl Acad Sci USA 94 1997 14683 14688
117. S.T. Olson, I. Bjrk, R. Sheffer, P.A. Craig, J.D. Shore, and J. Choay Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement J Biol Chem 267 1992 12528 12538
118. T. Bedsted, R. Swanson, Y.-J. Chuang, P.E. Bock, I. Bjrk, and S.T. Olson Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites Biochemistry 42 2003 8143 8152
119. P.G.W. Gettins, and S.T. Olson Activation of antithrombin as a factor IXa and Xa inhibitor involves mitigation of repression rather than positive enhancement FEBS Lett 583 2009 3397 3400
120. C. Manithody, L. Yang, and A.R. Rezaie Role of basic residues of the autolysis loop in the catalytic function of factor Xa Biochemistry 41 2002 6780 6788
121. L. Yang, C. Manithody, S.T. Olson, and A.R. Rezaie Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa J Biol Chem 278 2003 25032 25038
122. G. Izaguirre, and S.T. Olson Residues Tyr253 and Glu255 in strand 3 of β-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa J Biol Chem 281 2006 13424 13432
123. S.T. Olson, and I. Bjrk Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects J Biol Chem 266 1991 6353 6364
124. A.R. Rezaie Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism: evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa J Biol Chem 273 1998 16824 16827
125. G. Izaguirre, R. Swanson, S.M. Raja, A.R. Rezaie, and S.T. Olson Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin J Biol Chem 282 2007 33609 33622
126. S.T. Olson, R. Swanson, I. Verhamme, J. Kvassman, and J.D. Shore Resolution of Michaelis complex, acylation and conformational change steps in the reactions of the serpin PAI-1 with trypsin and tissue plasminogen activator Biochemistry 40 2001 11742 11756
127. S.T. Olson, and J.D. Shore Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. The reaction step limiting heparin turnover in thrombin neutralization J Biol Chem 261 1986 13151 13159
128. S.T. Olson Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of alpha-thrombin J Biol Chem 260 1985 10153 10160
129. A. Tabatabai, R. Fiehler, and G.J. Broze Jr. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor Thromb Haemost 85 2001 655 660
130. D.A. Lawrence, S. Palaniappan, S. Stefansson, S.T. Olson, A.M. Francis-Chmura, and J.D. Shore Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis J Biol Chem 272 1997 7676 7680
131. M.G. Schuster, P.M. Enriquez, P. Curran, B.S. Cooperman, and H. Rubin Regulation of neutrophil superoxide by antichymotrypsin-chymotrypsin complexes J Biol Chem 267 1992 5056 5059
132. 1 - Proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase J Biol Chem 263 1988 4481 4484
133. B. Richard, R. Swanson, S. Schedin-Weiss, B. Ramirez, G. Izaguirre, and P.G.W. Gettins Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin J Biol Chem 283 2008 14417 14429
134. R. Egelund, T.E. Petersen, and P.A. Andreasen A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate binding pocket and oxyanion hole in the serpin inhibitory mechanism Eur J Biochem 268 2001 673 685
135. J.C. Fredenburgh, A.R. Stafford, and J.I. Weitz Conformational changes in thrombin when complexed by serpins J Biol Chem 276 2001 32768
136. A.J. Scheidig, T.R. Hynes, L.A. Pelletier, J.A. Wells, and A.A. Kossiakoff Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid β-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities Protein Sci 6 1997 1806 1824
137. J.G. Grtter, J.P. Priestle, J. Rahuel, H. Grossenbacher, W. Bode, and J. Hofsteenge Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition EMBO J 9 1990 2361 2365
138. R.B. Sim, G. Arlaud, and M. Colomb Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s Biochim Biophys Acta 612 1980 433 449
139. Alpha1-Antitrypsin Deficiency Registry Study Group A registry of patients with severe deficiency of alpha1-antitrypsin Chest 106 1994 1223 1232
140. C. Benarafa, G.P. Priebe, and E. Remold-O'Donnell The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection J Exp Med 204 2007 1901 1909
141. C. Adiguzel, O. Iqbal, M. Demir, and J. Fareed European community and US-FDA approval of recombinant human antithrombin produced in genetically altered goats Clin Appl Thromb Hemost 15 2009 645 651
142. D. Yang, N. Nemkul, A. Shereen, A. Jone, R.S. Dunn, and D.A. Lawrence Therapeutic administration of plasminogen activator inhibitor-1 prevents hypoxic-ischemic brain injury in newborns J Neurosci 29 2009 8669 8674
143. E. Dai, H. Guan, L. Liu, S. Little, G. McFadden, and S. Vaziri Serp-1, a viral anti-inflammatory serpin, regulates cellular serine proteinase and serpin responses to vascular injury J Biol Chem 278 2003 18563 18572
144. G.S. Salvesen, and V.M. Dixit Caspases: intracellular signaling by proteolysis Cell 91 1997 443 446
145. P.M. George, M.C.M. Vissers, J. Travis, C.C. Winterbourn, and R.W. Carrell A genetically engineered mutant of α1-antitrypsin protects connective tissue from neutrophil damage and may be useful in lung disease Lancet 2 1984 1426 1428
146. M.C. Owen, S.O. Brennan, J.H. Lewis, and R.W. Carrell Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met to Arg), a fatal bleeding disorder N Engl J Med 309 1983 694 698
147. P.C.R. Hopkins, D.C. Crowther, R.W. Carrell, and S.R. Stone Development of a novel recombinant serpin with potential antithrimbotic properties J Biol Chem 270 1995 11866 11871
148. G. Izaguirre, A.R. Rezaie, and S.T. Olson Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically enhnace the inhibiiton of factor Xa and factor IXa J Biol Chem 284 2009 1550 1558
149. K.N. Lee, H. Im, S.W. Kang, and M.-H. Yu Characterization of a human α1-antitrypsin variant that is as stable as ovalbumin J Biol Chem 273 1998 2509 2516
150. F. Jean, K. Stella, L. Thomas, G. Liu, Y. Xiang, and G. Thomas α1-Antitrypsin Protland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent Proc Natl Acad Sci USA 95 1998 7293 7298
151. E.K. Dufour, J.-B. Denault, P.C.R. Hopkins, and R. Leduc Serpin-like properties of α1-antitrypsin Portland towards furin convertase FEBS Lett 426 1998 41 46
152. D.E. Bassi, R.L. DeCicco, H. Mahloogi, S. Zucker, G. Thomas, and A.J.P. Klein-Szanto Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells Proc Natl Acad Sci USA 98 2001 10326 10331
153. A. Tsuji, H. Kanie, H. Makise, K. Yuasa, M. Nagahama, and Y. Matsuda Engineering of α1-antitrypsin variants selective for subtilisin-like proprotein convertases PACE4 and PC6: importance of the P2′ residue in stable complex formation of the serpin with proprotein convertase Protein Eng Des Sel 20 2007 163 170
154. J.A. Irving, R.N. Pike, W. Dai, D. Bromme, D.M. Worrall, and G.A. Silverman Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering α1-antitrypsin to inhibit cathepsin proteases Biochemistry 41 2002 4998 5004
155. P.M. Sherman, D.A. Lawrence, A.Y. Yang, E.T. Vandenberg, D. Paielli, and S.T. Olson Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center J Biol Chem 267 1992 7588 7595
156. P.M. Sherman, D.A. Lawrence, I.M. Verhamme, D. Paielli, J.D. Shore, and D. Ginsburg Identification of tissue-type plasminogen activator-specific plasminogen activator inhibitor-1 mutants J Biol Chem 270 1995 9301 9306
157. S. Stefansson, M. Yepes, N. Gorlatova, D.E. Day, E.G. Moore, and A. Zabaleta Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors J Biol Chem 279 2004 29981 29987
158. J.M. Cale, and D.A. Lawrence Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent Curr Drug Targets 8 2007 971 981
159. A.A. Stoop, E. Eldering, T.R. Dafforn, R.J. Read, and H. Pannekoek Differential structural requirements for plasminogen activator inhibitor-1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries J Mol Biol 305 2001 773 783
160. S. Stefansson, and D. Lawrence The serpin PAI-1 inhibits cell migration by blocking integrin binding to vitronectin Nature 383 1996 441 443
161. S. Stefansson, E. Petitclerc, M.K. Wong, G.A. McMahon, P.C. Brooks, and D.A. Lawrence Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1 J Biol Chem 276 2001 8135 8141
162. J. Wu, L. Peng, G.A. McMahon, D.A. Lawrence, and W.P. Fay Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia Arterioscler Thromb Vasc Biol 29 2009 1565 1570
163. Y. Huang, W.A. Border, D.A. Lawrence, and N.A. Noble Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritis Am J Physiol Renal Physiol 297 2009 F1045 F1054
164. J. Huntington, B. Fan, K. Karlsson, J. Deinum, D. Lawrence, and P. Gettins Serpin conformational change in ovalbumin. Enhanced reactive center loop insertion through Hinge Region mutations Biochemistry 36 1997 5432 5440
165. M. Yamasaki, Y. Arii, B. Mikami, and M. Hirose Loop-inserted and thermostabilized structure of P1-P1′ cleaved ovalbumin mutant R339T J Mol Biol 315 2002 113 120
166. M. Onda, K. Nakatani, S. Takehara, M. Nishiyama, N. Takahashi, and M. Hirose Cleaved serpin refolds into the relaxed state via a stressed conformer J Biol Chem 283 2008 17568 17578
167. B.J. McCarthy, and D.M. Worrall Analysis of serpin inhibitory function by mutagenesis of ovalbumin and generation of chimeric ovalbumin/PAI-2 fusion proteins J Mol Biol 267 1997 561 569